Key Takeaways Prediabetes is a common, often symptomless condition driven by insulin resistance that can progress to type 2 diabetes without timely intervention
Healthy habits help reinforce the medications effects and support long-term weight management
Extensive clinical research has evaluated the hepatic safety profile of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists, with generally reassuring findings
The ESSENCE data may represent key findings for patients in the treatment of MASH, which is estimated to affect about one in 20 adults in the U.S., Dr
For detailed strategies on managing side effects throughout treatment, see our guide to Ozempic for weight loss, which covers semaglutide side effect management comprehensively
At the 1-2mg and 2.4 mg doses, non-diabetics lost more than diabetics